GRYPHON FINANCIAL PARTNERS LLC – Abbott Laboratories Transaction History
GRYPHON FINANCIAL PARTNERS LLC portfolio value:
$10.55M
portfolio value
GRYPHON FINANCIAL PARTNERS LLC quarter portfolio value change:
-10.94%
quarter
Abbott Laboratories 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +1.72% | 1.84K shares | -1.09M | $96.76 | 109.11K |
| Q2 2022 | share | Increase | +0.81% | 862 shares | -940K | $108.65 | 107.26K |
| Q1 2022 | share | Increase | +0.61% | 644 shares | -2.28M | $118.36 | 106.40K |
| Q4 2021 | share | Decrease | -0.17% | -181 shares | 2.37M | $141 | 105.75K |
| Q3 2021 | share | Increase | +1.18% | 1.24K shares | 389K | $117.68 | 105.94K |
| Q2 2021 | share | Decrease | -1.24% | -1.31K shares | -579K | $115.05 | 104.7K |
| Q1 2021 | share | Increase | +35.48% | 27.76K shares | 4.13M | $118.49 | 106.01K |
| Q4 2020 | share | Increase | +0.84% | 650 shares | 120K | $107.81 | 78.24K |
| Q3 2020 | share | Decrease | -3.76% | -3.02K shares | 1.07M | $106.81 | 77.59K |
| Q2 2020 | share | Decrease | -2.35% | -1.94K shares | 856K | $89.39 | 80.62K |
| Q1 2020 | share | Decrease | -2.50% | -2.11K shares | -840K | $76.84 | 82.57K |
| Q4 2019 | share | Decrease | -0.49% | -414 shares | 236K | $84.23 | 84.68K |
| Q3 2019 | share | Decrease | -0.23% | -200 shares | -54K | $80.81 | 85.09K |
| Q2 2019 | share | Increase | +1.94% | 1.62K shares | 485K | $80.92 | 85.29K |
| Q1 2019 | share | Decrease | -1.94% | -1.65K shares | 517K | $76.6 | 83.67K |
| Q4 2018 | share | Decrease | -1.18% | -1.01K shares | -163K | $68.98 | 85.33K |
| Q3 2018 | share | Increase | +2.12% | 1.79K shares | 1.17M | $69.69 | 86.35K |
| Q2 2018 | share | Decrease | -0.05% | -45 shares | 88K | $57.68 | 84.55K |
| Q1 2018 | share | Decrease | -1.08% | -925 shares | 188K | $56.4 | 84.60K |
| Q4 2017 | share | Increase | 0.00% | 85.52K shares | 4.88M | $53.46 | 85.52K |